On the Record · Sanofi
Sanofi acquisitions, on the record
The businesses Sanofi bought and sold, as its annual reports describe them, with the cash it reported paying for acquisitions each year and every deal filing since 2016.
Deals its annual reports describe
| Business | Deal | When | Value |
|---|---|---|---|
Provention Bio, Inc.Word for word“0001121404 sny:ProventionBioIncMember 2023-03-13 iso4217:USD xbrli:shares 0001121404 sny:ProventionBioIncMember 2023-03-13 0001121404 sny:ProventionBioIncMember 2023-04-27 0001121404 sny:ProventionBioIncMember 2023-01-01 2023-12-31 0001121404 sny:QRIBIntermediateHoldingsLLCMember 2023-09-29 0001121404 sny:QRIBIntermediateHoldingsLLCMember 2023-09-29 2023-12-31 0001121404 sny:QRIBIntermediateHoldingsLLCMember 2023-01-01 2023-12-31 0001121404 sny:AmunixPharmaceuticalsIncMember 2022-02-08 0001121404 sny:AmunixPharmaceuticalsIncMember 2022-02-08 2022-12-31 0001121404 sny:EuroapiMember 2022-03-17 2022-03-17 0001121404 sny:EuroapiMember sny:EPICBPIFranceMember 2022-03-17 0001121404 sny:EuroapiMember sny:EPICBPIFranceMember 2022-03-17 2022-03-17 0001121404 sny:EuroapiMember 2022-05-10 2022-12-31 0001121404 sny:EuroapiMember 2022-05-10 2022-05-10 0001121404 sny:EuroapiMember 2022-05-03 2022-05-03 0001121404 sny:EuroapiMember 2022-05-10 0001121404 sny:EuroapiMember 2021-01-01 2021-12-31 0001121404 sny:EuroapiMember sny:EPICBPIFranceMember 2022-06-17 2022-06-17 0001121404 sny:EuroapiMember sny:EPICBPIFranceMember 2022-06-17 0001121404 sny:EuroapiMember 2022-12-31 0001121404 ifrs-full:ProvisionForDecommissioningRestorationAndRehabilitationCostsMember 2022-05-10 0001121404 sny:RegulatoryComplianceCostsMember 2022-05-10 0001121404 sny:ManufactureAndSupplyCollaborationAgreementMember sny:EuroapiMember 2021-10-01 2021-10-01 0001121404 sny:ManufactureAndSupplyCollaborationAgreementMember sny:EuroapiMember 2021-10-01 0001121404 sny:ManufactureAndSupplyCollaborationAgreementMember sny:EuroapiMember 2022-12-31 0001121404 sny:KymabMember 2021-04-08 0001121404 sny:KymabMember 2021-01-01 2021-12-31 0001121404 sny:KiadisMember 2020-11-02 0001121404 sny:KiadisMember 2021-04-16 2021-04-16 0001121404 sny:KiadisMember 2021-04-29 2021-04-29 0001121404 sny:KiadisMember 2022-12-31 0001121404 sny:KiadisMember 2021-04-29 0001121404 sny:KiadisMember 2021-01-01 2021-12-31 0001121404 sny:TidalTherapeuticsMember 2021-04-09 0001121404 sny:TidalTherapeuticsMember 2021-01-01 2021-12-31 0001121404 sny:TranslateBioMember 2021-08-03 0001121404 sny:TranslateBioMember 2021-09-14 0001121404 sny:TranslateBioMember 2021-01-01 2021-12-31 0001121404 sny:TranslateBioMember 2020-06-23 0001121404 sny:KadmonMember 2021-11-09 0001121404 sny:KadmonMember 2021-11-09 2021-11-09 0001121404 sny:OrigimmBiotechnologyGmbHMember 2021-12-03 0001121404 sny:OrigimmBiotechnologyGmbHMember 2021-12-03 2021-12-03” 20-F for 2023 | acquisition | — | — |
Read from Sanofi’s annual reports (20-F for 2025, 20-F for 2024, 20-F for 2023) and the financial data it files with the SEC, as of 2026-02-17. Every quotation is word for word from the filing linked beside it; how these pages are built and checked. The full record is in its company data sheet.